Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joanne Mortimer

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
Journal of Geriatric Oncology|March 5, 2021
Phase II study of neratinib in older adults with HER2 amplified or HER2/3 mutated metastatic breast cancerYuan Yuan, Jin Sun Lee, Susan E Yost, et al.
The Oncologist|June 1, 2017
Association of Pre-Chemotherapy Peripheral Blood Pro-Inflammatory and Coagulation Factors with Physical Function in Women with Breast CancerYuan Yuan, Nilesh Vora, Can-Lan Sun, et al.
Cancer|January 21, 2021
Metabolic syndrome risk components and mortality after triple-negative breast cancer diagnosis in postmenopausal women in the Women's Health InitiativeYuan Yuan, Kathy Pan, Joanne Mortimer, et al.
NPJ Breast Cancer|December 3, 2025
Multi-institutional analysis of incidence and risks for late-onset immune toxicity in breast cancerSaya Jacob, Samantha Fisch, Carolyne Face, et al.
BMC Women'S Health|February 5, 2022
Cardiometabolic risk factors, physical activity, and postmenopausal breast cancer mortality: results from the Women's Health InitiativeChristina M Dieli-Conwright, Rebecca A Nelson, Michael S Simon, et al.
Cancer|April 17, 2024
Outcome prioritization and preferences among older adults with cancer starting chemotherapy in a randomized clinical trialEnrique Soto-Perez-de-Celis, William Dale, Vani Katheria, et al.
Breast Cancer Research : BCR|August 31, 2017
Association of pre-chemotherapy peripheral blood pro-inflammatory and coagulation factors with reduced relative dose intensity in women with breast cancerYuan Yuan, Nilesh Vora, Can-Lan Sun, et al.
Cell Metabolism|November 26, 2019
STAT3 Activation-Induced Fatty Acid Oxidation in CD8<sup>+</sup> T Effector Cells Is Critical for Obesity-Promoted Breast Tumor GrowthChunyan Zhang, Chanyu Yue, Andreas Herrmann, et al.
The Oncologist|November 3, 2020
A Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor-Positive Metastatic Triple-Negative Breast CancerYuan Yuan, Jin Sun Lee, Susan E Yost, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2008
NCCN Task Force Report: mTOR inhibition in solid tumorsRobert A Figlin, Elizabeth Brown, Andrew J Armstrong, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
Journal of Geriatric Oncology|March 5, 2021
Phase II study of neratinib in older adults with HER2 amplified or HER2/3 mutated metastatic breast cancerYuan Yuan, Jin Sun Lee, Susan E Yost, et al.
The Oncologist|June 1, 2017
Association of Pre-Chemotherapy Peripheral Blood Pro-Inflammatory and Coagulation Factors with Physical Function in Women with Breast CancerYuan Yuan, Nilesh Vora, Can-Lan Sun, et al.
Cancer|January 21, 2021
Metabolic syndrome risk components and mortality after triple-negative breast cancer diagnosis in postmenopausal women in the Women's Health InitiativeYuan Yuan, Kathy Pan, Joanne Mortimer, et al.
NPJ Breast Cancer|December 3, 2025
Multi-institutional analysis of incidence and risks for late-onset immune toxicity in breast cancerSaya Jacob, Samantha Fisch, Carolyne Face, et al.
BMC Women'S Health|February 5, 2022
Cardiometabolic risk factors, physical activity, and postmenopausal breast cancer mortality: results from the Women's Health InitiativeChristina M Dieli-Conwright, Rebecca A Nelson, Michael S Simon, et al.
Cancer|April 17, 2024
Outcome prioritization and preferences among older adults with cancer starting chemotherapy in a randomized clinical trialEnrique Soto-Perez-de-Celis, William Dale, Vani Katheria, et al.
Breast Cancer Research : BCR|August 31, 2017
Association of pre-chemotherapy peripheral blood pro-inflammatory and coagulation factors with reduced relative dose intensity in women with breast cancerYuan Yuan, Nilesh Vora, Can-Lan Sun, et al.
Cell Metabolism|November 26, 2019
STAT3 Activation-Induced Fatty Acid Oxidation in CD8<sup>+</sup> T Effector Cells Is Critical for Obesity-Promoted Breast Tumor GrowthChunyan Zhang, Chanyu Yue, Andreas Herrmann, et al.
The Oncologist|November 3, 2020
A Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor-Positive Metastatic Triple-Negative Breast CancerYuan Yuan, Jin Sun Lee, Susan E Yost, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2008
NCCN Task Force Report: mTOR inhibition in solid tumorsRobert A Figlin, Elizabeth Brown, Andrew J Armstrong, et al.
Pageof 11